Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72789-089

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72789-089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789089 Labels (72789089)

72789089 Labels (72789089)
Atorvastatin calcium USP 40 mg film-coated tablets label from PD-Rx Pharmaceuticals, Inc. The label includes the NDC 72789-089-30 and indicates a package size of 30 tablets. It shows dosage warnings, reorder number, lot number F20C70, and expiration date 06/2021. The label features a green and white logo for PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK.*
FDA Label Image

Figure-01 (Atorvastatin Figure 01)

Figure-01 (Atorvastatin Figure 01)
A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing lower cumulative incidence than the dashed line for placebo. The graph includes hazard ratio and p-value statistics indicating treatment effect.*
FDA Label Image

Figure-02 (Atorvastatin Figure 02)

Figure-02 (Atorvastatin Figure 02)
A line graph comparing the cumulative hazard percentage over a follow-up period of up to four years between Atorvastatin treatment and placebo. The graph shows two lines: a solid line for Atorvastatin and a dashed line for placebo, illustrating time to first primary endpoint. Hazard ratio and p-value are included on the graph.*
FDA Label Image

Figure-03 (Atorvastatin Figure 03)

Figure-03 (Atorvastatin Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over time (up to 5 years) for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value data.*
FDA Label Image

Structure (Atorvastatin Structure)

Structure (Atorvastatin Structure)
Chemical structure of Atorvastatin calcium, including its molecular components and calcium ion with three water molecules (trihydrate). The diagram displays the arrangement of atoms and chemical bonds characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.